A postzygotic GNA13 variant upregulates the RHOA/ROCK pathway and alters melanocyte function in a mosaic skin hypopigmentation syndrome

Rana El Masri, Alberto Iannuzzo, Paul Kuentz, Rachida Tacine, Marie Vincent, Sébastien Barbarot, Fanny Morice-Picard, Franck Boralevi, Naia Oillarburu, Juliette Mazereeuw-Hautier, Yannis Duffourd, Laurence Faivre, Arthur Sorlin, Pierre Vabres, Jérôme Delon
doi: https://doi.org/10.1101/2024.07.24.24310661

Article Information

doi 
https://doi.org/10.1101/2024.07.24.24310661
History 
  • July 24, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Rana El Masri1,12,
  2. Alberto Iannuzzo1,
  3. Paul Kuentz2,3,
  4. Rachida Tacine1,
  5. Marie Vincent4,
  6. Sébastien Barbarot5,
  7. Fanny Morice-Picard6,
  8. Franck Boralevi6,†,
  9. Naia Oillarburu7,
  10. Juliette Mazereeuw-Hautier7,
  11. Yannis Duffourd2,8,
  12. Laurence Faivre2,9,
  13. Arthur Sorlin2,10,13,
  14. Pierre Vabres2,10,11,*,# and
  15. Jérôme Delon1,*,#
  1. 1Université Paris Cité, CNRS, Inserm, Institut Cochin, F-75014 Paris, France
  2. 2UFR des Sciences de Santé, Inserm - Université de Bourgogne UMR1231 GAD "Génétique des Anomalies du Développement", FHU-TRANSLAD, Dijon, France
  3. 3Oncobiologie Génétique Bioinformatique, PCBio, Centre Hospitalier Universitaire de Besançon, Besançon, France
  4. 4Unité de Génétique clinique, Service de génétique médicale, CHU de Nantes - Hôpital Mère-Enfant, Nantes, France
  5. 5Nantes Université, Department of Dermatology, CHU Nantes, INRAE, UMR 1280, PhAN, F-44000 Nantes, France
  6. 6MAGEC Reference Centre for Rare Genetic Skin Diseases, Paediatric Dermatology Unit, Department of Dermatology, CHU de Bordeaux - GH Pellegrin, Bordeaux, France
  7. 7Service de dermatologie, CHU de Toulouse - Hôpital Larrey, Toulouse, France
  8. 8CHU Dijon, Unité Fonctionnelle "Innovation diagnostique dans les maladies rares", FHU-TRANSLAD & Institut GIMI, F-21000 Dijon, France
  9. 9CHU Dijon, Centre de Génétique et Centres de référence Anomalies du Développement et Déficience Intellectuelle, FHU-TRANSLAD & Institut GIMI, F-21000 Dijon, France
  10. 10MAGEC Reference Centre for Rare Genetic Skin Diseases and Paediatric Dermatology Unit, Department of Paediatrics, University Hospital Dijon-Bourgogne, FHU-TRANSLAD & Institut GIMI, F-21000 Dijon, France
  11. 11Rare Disease Collaborative Network (RDCN) Adult Mosaic Disorders Clinic, St John’s Institute of Dermatology, Guy’s and St Thomas’ NHS Foundation Trust, London SE1 7EH, United Kingdom
  1. ↵#Correspondence
    and requests for materials should be addressed to Pierre Vabres or Jérôme Delon. email: jerome.delon{at}inserm.fr

  1. ↵* Equal contributors. e-mails: vabres{at}u-bourgogne.fr; jerome.delon{at}inserm.fr

  • ↵12 Department of Cell Physiology & Metabolism, Faculty of Medicine, University of Geneva, Switzerland.

  • ↵13 National Center of Genetics (NCG), Laboratoire national de santé (LNS), 1 Rue Louis Rech, L-3555 Dudelange, Luxembourg.

Back to top
Posted July 24, 2024.
Download PDF

Supplementary Material

Data/Code
Email
A postzygotic GNA13 variant upregulates the RHOA/ROCK pathway and alters melanocyte function in a mosaic skin hypopigmentation syndrome
Rana El Masri, Alberto Iannuzzo, Paul Kuentz, Rachida Tacine, Marie Vincent, Sébastien Barbarot, Fanny Morice-Picard, Franck Boralevi, Naia Oillarburu, Juliette Mazereeuw-Hautier, Yannis Duffourd, Laurence Faivre, Arthur Sorlin, Pierre Vabres, Jérôme Delon
medRxiv 2024.07.24.24310661; doi: https://doi.org/10.1101/2024.07.24.24310661
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area